Post-approval studies (Phase 4)Ended earlyNCT00972543What this trial is testingRaptiva in Palm and Sole PsoriasisWho this might be right forChronic Plaque Psoriasis Merck KGaA, Darmstadt, Germany 6
Post-approval studies (Phase 4)Study completedNCT00493324What this trial is testingStudy to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis Astellas Pharma Inc 43
Not applicableLooking for participantsNCT04334031What this trial is testingDeployment o the Multidisciplinary Prospective Cohort ImminentWho this might be right forChronic Inflammatory DiseaseAngioedemaSevere Asthma+6 more University Hospital, Lille 2,200
Post-approval studies (Phase 4)Study completedNCT00932113What this trial is testingMechanism of Action Study for PsoriasisWho this might be right forPsoriasis Tufts Medical Center 33
Early research (Phase 1)Study completedNCT05461456What this trial is testingBioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%Who this might be right forAtopic DermatitisAtopic Dermatitis EczemaAtopic Rash+9 more OrchestratePharma GmbH 12
Not applicableStudy completedNCT05613712What this trial is testingChronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory MedicineWho this might be right forChronic Inflammatory Disease University Hospital, Grenoble 229
Testing effectiveness (Phase 2)Study completedNCT00770965What this trial is testingPhase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type PsoriasisWho this might be right forChronic Plaque Psoriasis Novartis Pharmaceuticals 80
Testing effectiveness (Phase 2)Study completedNCT03131570What this trial is testingSafety and Efficacy of Secukinumab in Mild PsoriasisWho this might be right forPsoriasis James G. Krueger, MD, PhD 23
Not applicableStudy completedNCT00678470What this trial is testingOpen Label Study of Alefacept Injections to Patients With Moderate to Severe PsoriasisWho this might be right forModerate to Severe Psoriasis University of California, San Francisco 18
Not applicableWithdrawnNCT01758705What this trial is testingPost Marketing Observational Study on Venezuelan Patients With PsoriasisWho this might be right forModerate to Severe Chronic Plaque Psoriasis AbbVie (prior sponsor, Abbott)
Large-scale testing (Phase 3)Study completedNCT02074982What this trial is testingEfficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type PsoriasisWho this might be right forChronic Plaque Type Psoriasis Novartis Pharmaceuticals 676
Large-scale testing (Phase 3)Study completedNCT00408187What this trial is testingRandomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis PatientsWho this might be right forPsoriasis Aurinia Pharmaceuticals Inc. 642
Not applicableStudy completedNCT00167752What this trial is testingPsychiatric Problems in Chronic Skin DiseasesWho this might be right forPsoriasisAcneVitiligo+2 more University of Wisconsin, Madison
Not applicableNot Yet RecruitingNCT07481019What this trial is testingA Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in DermatologyWho this might be right forChronic Dermatological ConditionsEczemaUrticaria+1 more National University Hospital, Singapore 250
Testing effectiveness (Phase 2)Study completedNCT02905006What this trial is testingStudy to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis UCB Biopharma S.P.R.L. 250
Large-scale testing (Phase 3)Study completedNCT00679731What this trial is testingSafety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis AbbVie (prior sponsor, Abbott) 317
Post-approval studies (Phase 4)UnknownNCT05555797What this trial is testingExcimer Laser With Topical Agents in Psoriasis VulgarisWho this might be right forPsoriasis Assiut University 30
Large-scale testing (Phase 3)Study completedNCT02016482What this trial is testingEvaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail PsoriasisWho this might be right forNail PsoriasisPlaque Psoriasis AbbVie 217
Large-scale testing (Phase 3)Study completedNCT03066609What this trial is testingStudy of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type PsoriasisWho this might be right forPlaque Psoriasis Novartis Pharmaceuticals 543
Large-scale testing (Phase 3)Study completedNCT04930042What this trial is testingEfficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Alvotech Swiss AG 581